{"id":16630,"date":"2022-02-03T12:40:10","date_gmt":"2022-02-03T17:40:10","guid":{"rendered":"https:\/\/arsacs.com\/?p=16630"},"modified":"2022-02-03T12:57:41","modified_gmt":"2022-02-03T17:57:41","slug":"prospax-sondage-phase-2","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/","title":{"rendered":"PROSPAX Sondage Phase 2"},"content":{"rendered":"\n<h5 class=\"wp-block-heading\"><\/h5>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p id=\"block-89228332-0ef5-4012-a2ac-aabb13ae2e35\">Opportunit\u00e9 de vous faire entendre. Faites savoir aux chercheurs ce qui est important pour vous et comment vous vous sentez vivant avec la maladie. <strong>Vous n\u2019avez pas besoin d\u2019avoir r\u00e9pondu au premier sondage pour r\u00e9pondre \u00e0 ce sondage.<\/strong> Un parent d&#8217;un enfant peut remplir le questionnaire.<\/p>\n\n\n\n<p id=\"block-89228332-0ef5-4012-a2ac-aabb13ae2e35\">PROSPAX est un projet international de 3 ans ax\u00e9 sur l\u2019ARSACS et SPG7. Cliquez sur le bouton ci-dessous pour participer. <\/p>\n\n\n\n<p id=\"block-89228332-0ef5-4012-a2ac-aabb13ae2e35\">Date limite : le 28 f\u00e9vrier 2022. <\/p>\n\n\n\n<p>Tous ensemble nous pouvons faire avancer la recherche sur l\u2019ARSACS. Merci pour votre participation.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><a href=\"https:\/\/ec.europa.eu\/eusurvey\/runner\/PROSPAXSurvey2_FC\">PROSPAX Sondage Phase 2 <\/a><\/p>\n\n\n\n<h6 class=\"wp-block-heading\"><\/h6>\n\n\n\n<h6 class=\"wp-block-heading\"><\/h6>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<h5 class=\"wp-block-heading\"><\/h5>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<pre id=\"tw-target-text\" class=\"wp-block-preformatted\"><\/pre>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Opportunit\u00e9 de vous faire entendre. Faites savoir aux chercheurs ce qui est important pour vous et comment vous vous sentez vivant avec la maladie. Vous n\u2019avez pas besoin d\u2019avoir r\u00e9pondu au premier sondage pour r\u00e9pondre \u00e0 ce sondage. Un parent d&#8217;un enfant peut remplir le questionnaire. PROSPAX est un projet international de 3 ans ax\u00e9 [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":16645,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[28],"tags":[],"class_list":["post-16630","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dernieres-nouvelles"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PROSPAX Sondage Phase 2 - ARSACS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PROSPAX Sondage Phase 2 - ARSACS\" \/>\n<meta property=\"og:description\" content=\"Opportunit\u00e9 de vous faire entendre. Faites savoir aux chercheurs ce qui est important pour vous et comment vous vous sentez vivant avec la maladie. Vous n\u2019avez pas besoin d\u2019avoir r\u00e9pondu au premier sondage pour r\u00e9pondre \u00e0 ce sondage. Un parent d&#8217;un enfant peut remplir le questionnaire. PROSPAX est un projet international de 3 ans ax\u00e9 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/\" \/>\n<meta property=\"og:site_name\" content=\"ARSACS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100044457429916\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-03T17:40:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-03T17:57:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/arsacs.com\/wp-content\/uploads\/2022\/02\/Crop_PROSPAX-LOGO-e1664463589855.png\" \/>\n\t<meta property=\"og:image:width\" content=\"922\" \/>\n\t<meta property=\"og:image:height\" content=\"971\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ARSACS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ARSACS\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/\"},\"author\":{\"name\":\"ARSACS\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#\\\/schema\\\/person\\\/93b66d6b897bfa131622d04b767b15f1\"},\"headline\":\"PROSPAX Sondage Phase 2\",\"datePublished\":\"2022-02-03T17:40:10+00:00\",\"dateModified\":\"2022-02-03T17:57:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/\"},\"wordCount\":96,\"publisher\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Crop_PROSPAX-LOGO-e1664463589855.png\",\"articleSection\":[\"Derni\u00e8res Nouvelles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/\",\"url\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/\",\"name\":\"PROSPAX Sondage Phase 2 - ARSACS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Crop_PROSPAX-LOGO-e1664463589855.png\",\"datePublished\":\"2022-02-03T17:40:10+00:00\",\"dateModified\":\"2022-02-03T17:57:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Crop_PROSPAX-LOGO-e1664463589855.png\",\"contentUrl\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Crop_PROSPAX-LOGO-e1664463589855.png\",\"width\":922,\"height\":971},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/prospax-sondage-phase-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/arsacs.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PROSPAX Sondage Phase 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#website\",\"url\":\"https:\\\/\\\/arsacs.com\\\/\",\"name\":\"Fondation de l'Ataxie Charlevoix-Saguenay\",\"description\":\"Research That Heals\",\"publisher\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/arsacs.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#organization\",\"name\":\"ARSACS\",\"url\":\"https:\\\/\\\/arsacs.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo_ARSACS_fr_flat.png\",\"contentUrl\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo_ARSACS_fr_flat.png\",\"width\":291,\"height\":84,\"caption\":\"ARSACS\"},\"image\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=100044457429916\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#\\\/schema\\\/person\\\/93b66d6b897bfa131622d04b767b15f1\",\"name\":\"ARSACS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g\",\"caption\":\"ARSACS\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PROSPAX Sondage Phase 2 - ARSACS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/","og_locale":"fr_FR","og_type":"article","og_title":"PROSPAX Sondage Phase 2 - ARSACS","og_description":"Opportunit\u00e9 de vous faire entendre. Faites savoir aux chercheurs ce qui est important pour vous et comment vous vous sentez vivant avec la maladie. Vous n\u2019avez pas besoin d\u2019avoir r\u00e9pondu au premier sondage pour r\u00e9pondre \u00e0 ce sondage. Un parent d&#8217;un enfant peut remplir le questionnaire. PROSPAX est un projet international de 3 ans ax\u00e9 [&hellip;]","og_url":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/","og_site_name":"ARSACS","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100044457429916","article_published_time":"2022-02-03T17:40:10+00:00","article_modified_time":"2022-02-03T17:57:41+00:00","og_image":[{"width":922,"height":971,"url":"https:\/\/arsacs.com\/wp-content\/uploads\/2022\/02\/Crop_PROSPAX-LOGO-e1664463589855.png","type":"image\/png"}],"author":"ARSACS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ARSACS"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/#article","isPartOf":{"@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/"},"author":{"name":"ARSACS","@id":"https:\/\/arsacs.com\/#\/schema\/person\/93b66d6b897bfa131622d04b767b15f1"},"headline":"PROSPAX Sondage Phase 2","datePublished":"2022-02-03T17:40:10+00:00","dateModified":"2022-02-03T17:57:41+00:00","mainEntityOfPage":{"@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/"},"wordCount":96,"publisher":{"@id":"https:\/\/arsacs.com\/#organization"},"image":{"@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/#primaryimage"},"thumbnailUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2022\/02\/Crop_PROSPAX-LOGO-e1664463589855.png","articleSection":["Derni\u00e8res Nouvelles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/","url":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/","name":"PROSPAX Sondage Phase 2 - ARSACS","isPartOf":{"@id":"https:\/\/arsacs.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/#primaryimage"},"image":{"@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/#primaryimage"},"thumbnailUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2022\/02\/Crop_PROSPAX-LOGO-e1664463589855.png","datePublished":"2022-02-03T17:40:10+00:00","dateModified":"2022-02-03T17:57:41+00:00","breadcrumb":{"@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/#primaryimage","url":"https:\/\/arsacs.com\/wp-content\/uploads\/2022\/02\/Crop_PROSPAX-LOGO-e1664463589855.png","contentUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2022\/02\/Crop_PROSPAX-LOGO-e1664463589855.png","width":922,"height":971},{"@type":"BreadcrumbList","@id":"https:\/\/arsacs.com\/fr\/prospax-sondage-phase-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/arsacs.com\/"},{"@type":"ListItem","position":2,"name":"PROSPAX Sondage Phase 2"}]},{"@type":"WebSite","@id":"https:\/\/arsacs.com\/#website","url":"https:\/\/arsacs.com\/","name":"Fondation de l'Ataxie Charlevoix-Saguenay","description":"Research That Heals","publisher":{"@id":"https:\/\/arsacs.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/arsacs.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/arsacs.com\/#organization","name":"ARSACS","url":"https:\/\/arsacs.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/arsacs.com\/#\/schema\/logo\/image\/","url":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/06\/logo_ARSACS_fr_flat.png","contentUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/06\/logo_ARSACS_fr_flat.png","width":291,"height":84,"caption":"ARSACS"},"image":{"@id":"https:\/\/arsacs.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100044457429916"]},{"@type":"Person","@id":"https:\/\/arsacs.com\/#\/schema\/person\/93b66d6b897bfa131622d04b767b15f1","name":"ARSACS","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g","caption":"ARSACS"}}]}},"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/16630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=16630"}],"version-history":[{"count":8,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/16630\/revisions"}],"predecessor-version":[{"id":16651,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/16630\/revisions\/16651"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media\/16645"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=16630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=16630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=16630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}